State of the art: Transplantation in HIV infected individuals  by Brito, M.
e al of I
v
t
r
A
r
c
c
i
b
w
c
a
a
T
c
v
f
f
p
r
a
p
d
t
r
h
T
F
S
D
T
R
T
N
s
i
l
p
i
t
t
p
S
p
p
c
p
t
e
a58 15th ICID Abstracts / International Journ
accine. Information in thispaperwasusedbyanti-vaccineactivists
o argue against the use of MMR and led to decreased coverage and
esultant measles outbreaks.
A policy change in 1999 recommended by the American
cademy of Pediatrics and the US Centers for Disease Control to
emove thimerosal from vaccines fueled the rumor that thimerosal
aused autism. This rumor resulted in thousands of claims of vac-
ine injury and a decrease in the rate of neonatal hepatitis B
mmunization.
In 2003 religious and political leaders in Nigeria encouraged
oycotts of oral polio vaccine, claiming that it was contaminated
ith HIV and could cause sterilization in vaccinees. This politi-
ally motivated assertion resulted in a polio outbreak in Nigeria
nd subsequent polio outbreaks in 15 other countries.
A 1994 report on a birth control vaccine using tetanus toxoid as
carrier sparked a rumor that tetanus toxoid could cause sterility.
his misinformation, spread by Catholic organizations through 60
ountries in South and Central America, resulted in a 45% drop in
accination coverage.
The intuitive approach to combating vaccinemyths is to provide
actual information to refute the myth. The method by which the
actual information is presented is important. Research onmemory
erformance demonstrated that repetition of a myth in order to
efute it frequently led to the false information being remembered
s true.
To effectively face anti-vaccine movements the full range of
olitical, cultural, and psychological factors affecting individual
ecision making must be considered and used in building public
rust. In view of the way human memory works, presentation and
epetition of facts should replace reiteration of the false myths.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.141
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he pre-transplant evaluation
. Smitasin
Vejthani Hospital, Bangkok, Thailand
The science of transplantation has advanced tremendously
ince the discovery of immunosuppressive agents. With the potent
mmunosuppressive agents but less adverse effects, patient can live
onger and has better quality of life. In order to achieve this goal,
re-transplant evaluation is crucial in decreasing and eliminating
nfectious complications after immunosuppression.
The objectives of pre-transplant evaluation are to identify and
reat active infection, deﬁne the risk of infection and implement
he strategies to prevent infection post-transplant period.
Detail history taking is the key to successfully managing and
reventing infectious complication pre- and post-transplantation.
erological and immunological tests for infections, such as her-
es virus, syphilis, HIV and Mycobacterium tuberculosis, identify
atients with latent infections which lead to pre-transplant vac-
ination, treatment and appropriate post-transplant antimicrobial
rophylaxis. Patient with active infection should be treated in
imely fashion prior to intense immunosuppression to avoid exac-
rbation of the disease. History of travel, occupation and daily
ctivity suggests speciﬁc tests of infections in each geographicalnfectious Diseases 16S (2012) e2–e157
area. Life-style modiﬁcation is recommended in order to decrease
exposure to infection pre- and post-transplantation.
http://dx.doi.org/10.1016/j.ijid.2012.05.142
Type: Invited Presentation
Final Abstract Number: 34.002
Session: Infectious Issues in Transplantation
Date: Saturday, June 16, 2012
Time: 10:15-12:15
Room: Lotus 5-7
Donor derived infections
G. Reid
University of Illinois, Chicago, IL, USA
Infections are a signiﬁcant complication of solid organ trans-
plantations (SOT). Although many of these infections are due to
surgical complications and pre- and posttransplant exposure of
immunocompromised individuals to pathogens in the hospital
and in their daily activities at home, another potential source of
infection in these individuals derives from their donors. Usually
cadaveric donors are not known and family members giving con-
sent may not know all of their history. In such cases the life saving
organs can potentially pose a threat to the lives of the recipients
they were meant to save.
Several methods can decrease risk of this occurring: screen-
ing of donor medical, social, and travel history, and screening of
donor blood for not only common infectious contraindications,
such as HIV and viral hepatitis, but also infections endemic to
their travel history. Additionally, having tightly regulated policies,
autopsy conﬁrmation of cause of death and comorbidities of donor,
and ease of communication between transplant centers can con-
tribute to decreasing morbidity and mortality from donor derived
infections.
Having a framework in place to address the risk of donor derived
infections at numerous levels is key to decreasing the likelihood
of this potentially catastrophic event, which can affect numerous
recipients’ lives.
http://dx.doi.org/10.1016/j.ijid.2012.05.143
Type: Invited Presentation
Final Abstract Number: 34.003
Session: Infectious Issues in Transplantation
Date: Saturday, June 16, 2012
Time: 10:15-12:15
Room: Lotus 5-7
State of the art: Transplantation in HIV infected individuals
M. Brito
University of Illinois at Chicago, Chicago, IL, USA
The introduction of Highly Active Antiretroviral Therapy in the
mid-1990’s has had a signiﬁcant impact in the morbidity and
mortality of patients infected with the Human Immunodeﬁciency
Virus (HIV). Diseases previously deemed untreatable in this patient
population are now the focus of intense research. Cirrhosis and
decompensated liver disease, secondary to a more rapid progres-
sion of Hepatitis C virus infection, and end-stage renal disease,
cause signiﬁcant morbidity in otherwise healthy and virologically
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ell-controlled HIV patients. The occurrence of these complica-
ions has brought to the surface the need for a better understanding
f organ transplantation in this population. Their care is complex
nd requires expertise. Issues of graft survival, opportunistic infec-
ions, an increase in comorbidities, and the various interactions
etween the immunosuppressive drugs and the antiretrovirals, are
ll situations that present a challenge to the infectious diseases
ractitioner. In this lecture, Dr. Brito will review the most com-
on indications for liver and kidney transplants, the epidemiology,
ost surgical outcomes, and some special management scenarios
ncountered in clinical practice.
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ommon respiratory viral infections
. Kaiser
Laboratoire de Virologie, Geneva, Switzerland
Respiratory viruses are certainly the most common viruses
nfecting humans. Thanks to the availability of modern molecu-
ar screening these viruses are frequently recovered in the upper or
he lower respiratory tract of hospitalized patients. It is thus impor-
ant to understand not only the epidemiology but also the potential
linical impact of these agents. Across all population studied the
ost frequent viruses are the so-called common cold viruses like
hinoviruses and coronaviruses. What is the real impact of these
iruses, are they innocent bystanders? Are these viruses causing
espiratory symptoms and lower respiratory tract infections? The
iological and clinical diversity of viral respiratory diseases will
e reviewed as well as the epidemiology and the clinical conse-
uences of these infections in transplant recipients. Large cohorts
tudies conducted in lung transplant recipients will be presented.
he potential available treatment interventions in transplant recip-
ents will also be discussed.
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onfronting tuberculosis in the era of HIV
. Lawn
University of Cape Town, Cape Town, South Africa
The HIV-associated tuberculosis (TB) epidemic remains a huge
hallenge to TB control in countrieswithhighprevalenceofHIVand
s a substantial obstacle to progress towards attainment of the Mil-
ennium Development Goals and associated STOP TB targets for TB
ontrol. This talk will summarize the current approach to control
f this epidemic and then will focus in detail on two key issues.nfectious Diseases 16S (2012) e2–e157 e59
(i) The huge challenge of diagnosis of HIV-associated TB funda-
mentally undermines our response to this epidemic. This talk will
review the very promising developments in TB diagnostics that for
the ﬁrst time permit rapid and point-of-care diagnosis of sputum
smear-negative TB in patients with advanced immunodeﬁciency.
(ii) It is abundantly clear that we cannot treat our way out of this
epidemic using the DOTS TB control strategy and additional TB pre-
ventive intervention are needed. This talk will highlight the impact
of ART to serve as the key TB preventive intervention, describing
in detail its impact on individual risk as well as the impact at the
community level. The preventive potential of ART is largely being
squandered at present and the potential for the ‘Test and Treat’
strategy to have a much greater impact will be discussed.
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Innate immune recognition and response to pathogens
S. Akira
Osaka University, Osaka, Japan
Our laboratory studies mechanisms of innate immunity.
Through generation of knockout mice, we have demonstrated
that a family of Toll-like receptors (TLR) recognizes a variety of
PAMPs such as lipopolysaccharide, lipoprotein and nucleic acids
derived frombacteria, viruses andprotozoa to elicit innate immune
responses. We have also demonstrated that a family of RIG-I-like
RNA helicases (RLR) including RIG-I and MDA5 participates in TLR-
independent recognition of nucleic acids derived from different
types of RNA viruses in the cytoplasm. NOD-like receptors(NLR)
also sense microbial components in the cytoplasm of cells. Several
C-type lectin receptors(CLR) are shown to recognize the carbohy-
drates frompathogens.Here Iwill talk about the anti-viral response
by neutrophil extracellular DNA trap(NET) and ZAP.
http://dx.doi.org/10.1016/j.ijid.2012.05.147
Type: Invited Presentation
Final Abstract Number: 36.002
Session: Innate Immunity and Infectious Diseases
Date: Saturday, June 16, 2012
Time: 15:45-17:45
Room: Ballroom A
Innate immune recognition of an AT-rich stem-loop DNA motif
in the Plasmodium falciparum genome
D. Golenbock
University Massachusetts Medical School, Worcester, MA, USA
Malarial infections lead to signiﬁcant morbidity and mortal-
ity worldwide. The genome ofPlasmodium falciparumis the most
AT-rich of any genome studied; it has over 6000 ATTTTTAC (“AT-
rich”) motifs, which we now show activate human and murine
cells to produce inﬂammatory cytokines and type I Interferons.
Induction of type I IFNs byPlasmodium-derived AT-rich DNA is
